Daijiworld Media Network- Panaji

Panaji, Aug 14: In a landmark healthcare initiative, Goa has become the first state in the country to introduce a policy framework for negotiating reduced prices for life-saving therapies, giving a major boost to patients battling cancer and rare diseases.

Health minister Vishwajit Rane announced on Wednesday that the policy will enable the state government to procure essential drugs, medical equipment, and diagnostic services from pharmaceutical companies at negotiated rates significantly lower than their listed prices. The savings will allow the government to extend treatment to more patients or support longer therapy durations.

The rollout is expected to begin with therapies for lung cancer. “Goa’s adoption of this pricing policy is a vital and timely step towards health equity. This value-based approach will enhance patient access and marks a new era in prioritising life-saving treatments,” Rane said.

Currently, innovative therapies for conditions such as cancer, rare genetic disorders, and autoimmune diseases can cost over ?50 lakh per year — an expense beyond the reach of most families. Goa, which records about 1,500 new cancer cases annually, ranks in the upper quartile among Indian states for cancer incidence. Breast cancer leads with over 300 cases a year, followed by oral cavity cancers, accounting for 20–25% of total cases.

To oversee implementation, the government will set up a committee chaired by the additional or joint secretary of health, with members including the Dean of Goa Medical College, Director of Health Services, and pharmacy heads. This body will recommend appropriate pricing and negotiate with companies for patented drugs and equipment, with all agreements maintaining strict confidentiality.

Rane emphasised that the move will strengthen Goa’s healthcare system in tackling the rising cancer burden, which is projected to grow by 5% annually, alongside the increasing prevalence of rare diseases.